Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan…
Pharmaceuticals, Biotechnology and Life Sciences
Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan…
LEXINGTON, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing…
Saint-Herblain (France), April 20, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic…
BOSTON, April 20, 2021 (GLOBE NEWSWIRE) — Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter…
MARLBOROUGH, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused…
Eddie L. Varnado joins Lumos Pharma as Vice President, Finance and Corporate ControllerAUSTIN, Texas, April 20, 2021 (GLOBE NEWSWIRE) —…
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…
Company’s Confidence Continues to Grow on Implementation of Proposed Nicotine Cap and Menthol Ban Company is Fully Prepared to Launch…
Treatment Difference between EDP1815 and Placebo for EASI, IGA*BSA, and SCORAD throughout the study treatment period Data presented at the…